Abstract
Experimental and clinical findings suggest a crucial role for inflammation in the onset of pediatric seizures; this mechanism is not targeted by conventional antiepileptic drugs and may contribute to refractory epilepsy. Several triggers, including infection with neurotropic viruses such as human herpesvirus 6 (HHV-6), other herpesviruses, and picornaviruses, appear to induce activation of the innate and adaptive immune systems, which results in several neuroinflammatory responses, leading to enhanced neuronal excitability, and ultimately contributing to epileptogenesis. This review discusses the proposed mechanisms by which infection with herpesviruses, and particularly with HHV-6, and ensuing inflammation may lead to seizure generation, and later development of epilepsy. We also examine the evidence that links herpesvirus and picornavirus infections with acute seizures and chronic forms of epilepsy. Understanding the mechanisms by which specific viruses may trigger a cascade of alterations in the CNS ultimately leading to epilepsy appears critical for the development of therapeutic agents that may target the virus or inflammatory mechanisms early and prevent progression of epileptogenesis.
Similar content being viewed by others
References
Ekstrand JJ, Herbener A, Rawlings J, Turney B, Ampofo K, Korgenski EK, Bonkowsky JL (2010) Heightened neurologic complications in children with pandemic H1N1 influenza. Ann Neurol 68:762–766
Murthy JMK (2010) Neurological complications of dengue infection. Neurol India 58:581–584
Solomon T, Vaughn DW (2002) Pathogenesis and clinical features of Japanese encephalitis and West Nile virus infections. Curr Top Microbiol Immunol 267:171–194
Owatanapanich S, Wutthanarungsan R, Jaksupa W, Thisyakorn U (2016) Risk factors for severe enteroviral infections in children. J Med Assoc Thail 99:322–330
Britton PN, Dale RC, Nissen MD, Crawford N, Elliott E, Macartney K, Khandaker G, Booy R et al (2016) Parechovirus encephalitis and neurodevelopmental outcomes. Pediatrics 137:e20152848
Karsch K, Obermeier P, Seeber L, Chen X, Tief F, Mühlhans S, Hoppe C, Conrad T et al (2015) Human parechovirus infections associated with seizures and rash in infants and toddlers. Pediatr Infect Dis J 34:1049–1055
Theodore WH (2014) Epilepsy and viral infections. Epilepsy Curr 14:35–42
Laina I, Syriopoulou VP, Daikos GL, Roma ES, Papageorgiou F, Kakourou T, Theodoridou M (2010) Febrile seizures and primary human herpesvirus 6 infection. Pediatr Neurol 42:28–31
Epstein LG, Shinnar S, Hesdorffer DC, Nordli DR, Hamidullah A, Benn EK, Pellock JM, Frank LM et al (2012) Human herpesvirus 6 and 7 in febrile status epilepticus: the FEBSTAT study. Epilepsia 53:1481–1488
Fotheringham J, Donati D, Akhyani N, Fogdell-Hahn A, Vortmeyer A, Heiss JD, Williams E, Weinstein S et al (2007) Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med 4:e180
Annegers JF, Hauser WA, Beghi E, Nicolosi A, Kurland LT (1988) The risk of unprovoked seizures after encephalitis and meningitis. Neurology 38:1407–1410
Vezzani A, Fujinami RS, White HS, Preux PM, Blümcke I, Sander JW, Löscher W (2016) Infections, inflammation and epilepsy. Acta Neuropathol 131:211–234
Löscher W, Brandt C (2010) Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research. Pharmacol Rev 62:668–700
Xanthos DN, Sandkuhler J (2014) Neurogenic neuroinflammation: inflammatory CNS reactions in response to neuronal activity. Nat Rev Neurosci 15:43–53
Aronica E, Bauer S, Bozzi Y, Caleo M, Dingledine R, Gorter JA, Henshall DC, Kaufer D et al (2017) Neuroinflammatory targets and treatments for epilepsy validated in experimental models. Epilepsia 58:27–38
van Vliet EA, Aronica E, Vezzani A, Ravizza T (2018) Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathol Appl Neurobiol 44:91–111
Jyonouchi H, Geng L (2016) Intractable epilepsy (IE) and responses to Anakinra, a human recombinant IL-1 receptor agonist (IL-1ra): Case reports. J Clin Cell Immunol 7:–5
Kenney-Jung DL, Vezzani A, Kahoud RJ, LaFrance-Corey RG, Ho ML, Muskardin TW, Wirrell EC, Howe CL et al (2016) Febrile infection-related epilepsy syndrome treated with anakinra. Ann Neurol 80:939–945
Balosso S, Liu J, Bianchi ME, Vezzani A (2014) Disulfide-containing high mobility group box-1 promotes N-methyl-D-aspartate receptor function and excitotoxicity by activating Toll-like receptor 4-dependent signaling in hippocampal neurons. Antioxid Redox Signal 21:1726–1740
Vezzani A, Viviani B (2015) Neuromodulatory properties of inflammatory cytokines and their impact on neuronal excitability. Neuropharmacology 96:70–82
Viviani B, Gardoni F, Marinovich M (2007) Cytokines and neuronal ion channels in health and disease. Int Rev Neurobiol 82:247–263
Beattie EC, Stellwagen D, Morishita W, Bresnahan JC, Ha BK, Von Zastrow M, Beattie MS, Malenka RC (2002) Control of synaptic strength by glial TNFalpha. Science 295:2282–2285
Stellwagen D, Beattie EC, Seo JY, Malenka RC (2005) Differential regulation of AMPA receptor and GABA receptor trafficking by tumor necrosis factor-alpha. J Neurosci 25:3219–3228
Roseti C, van Vliet EA, Cifelli P, Ruffolo G, Baayen JC, Di Castro MA, Bertollini C, Limatola C et al (2015) GABAA currents are decreased by IL-1β in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis. Neurobiol Dis 82:311–320
Allan SM, Tyrrell PJ, Rothwell NJ (2005) Interleukin-1 and neuronal injury. Nat Rev Immunol 5:629–640
Ferrari CC, Depino AM, Prada F, Muraro N, Campbell S, Podhajcer O, Perry VH, Anthony DC et al (2004) Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain. Am J Pathol 165:1827–1837
Librizzi L, Noè F, Vezzani A, de Curtis M, Ravizza T (2012) Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage. Ann Neurol 72:82–90
Cacheaux LP, Ivens S, David Y, Lakhter AJ, Bar-Klein G, Shapira M, Heinemann U, Friedman A et al (2009) Transcriptome profiling reveals TGF-beta signaling involvement in epileptogenesis. J Neurosci 29:8927–8935
Friedman A, Kaufer D, Heinemann U (2009) Blood-brain barrier breakdown-inducing astrocytic transformation: novel targets for the prevention of epilepsy. Epilepsy Res 85:142–149
Kim SY, Senatorov VV Jr, Morrissey CS, Lippmann K, Vazquez O, Milikovsky DZ, Gu F, Parada I et al (2017) TGFβ signaling is associated with changes in inflammatory gene expression and perineuronal net degradation around inhibitory neurons following various neurological insults. Sci Rep 7:7711
Frigerio F, Frasca A, Weissberg I, Parrella S, Friedman A, Vezzani A, Noé FM (2012) Long-lasting pro-ictogenic effects induced in vivo by rat brain exposure to serum albumin in the absence of concomitant pathology. Epilepsia 53:1887–1897
Bar-Klein G, Cacheaux LP, Kamintsky L, Prager O, Weissberg I, Schoknecht K, Cheng P, Kim SY et al (2014) Losartan prevents acquired epilepsy via TGF-β signaling suppression. Ann Neurol 75:864–875
Aronica E, Ravizza T, Zurolo E, Vezzani A (2012) Astrocyte immune responses in epilepsy. Glia 60:1258–1268
Devinsky O, Vezzani A, Najjar S, De Lanerolle NC, Rogawski MA (2013) Glia and epilepsy: excitability and inflammation. Trends Neurosci 36:174–184
Zerr DM, Meier AS, Selke SS, Frenkel LM, Huang ML, Wald A, Rhoads MP, Nguy L et al (2005) A population-based study of primary human herpesvirus 6 infection. N Engl J Med 352:768–776
Theodore WH, Epstein L, Gaillard WD, Shinnar S, Wainwright MS, Jacobson S (2008) Human herpes virus 6B: a possible role in epilepsy? Epilepsia 49:1828–1837
Morissette G, Flamand L (2010) Herpesviruses and chromosomal integration. J Virol 84:12100–12109
Hill JA, Venna N (2014) Human herpesvirus 6 and the nervous system. Handb Clin Neurol 123:327–355
Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A et al (2012) Chromosomally integrated human herpesvirus 6: questions and answers. Rev Med Virol 22:144–155
Sweetman LL, Ng YT, Butler IJ, Bodensteiner JB (2005) Neurologic complications associated with respiratory syncytial virus. Pediatr Neurol 32:307–310
Chiu SS, Tse CYC, Lau YL, Peiris M (2001) Influence A infection is an important cause of febrile seizures. Pediatrics 108:1004–1005
Kawada JI, Kimura H, Ito Y, Hara S, Iriyama M, Yoshikawa T, Morishima T (2003) Systemic cytokine responses in patients with influenza-associated encephalopathy. J Infect Dis 188:690–698
Mazarati AM (2005) Cytokines: a link between fever and seizures. Epilepsy Curr 5:169–170
Bertolani MF, Portolani M, Marotti F, Sabbattini AM, Chiossi C, Bandieri MR, Cavazzuti GB (1996) A study of childhood febrile convulsions with particular reference to HHV-6 infection: Pathogenic considerations. Childs Nerv Syst 12:534–539
Millichap JG, Millichap JJ (2006) Role of viral infections in the etiology of febrile seizures. Pediatr Neurol 35:165–172
Hall CB, Long CE, Schnabel KC, Caserta MT, McIntyre KM, Costanzo MA, Knott A, Dewhurst S et al (1994) Human herpesvirus-6 infection in children. A prospective study of complications and reactivation. N Engl J Med 331:432–438
Chua KB, Lam SK, AbuBakar S, Koh MT, Lee WS (1997) The incidence of human herpesvirus 6 infection in children with febrile convulsion admitted to the university hospital, Kuala Lumpur. Med J Malaysia 52:335–341
Pancharoen C, Chansongsakul T, Bhattarakosol P (2000) Causes of fever in children with first febrile seizures: how common are human herpesvirus-6 and dengue virus infection? Southeast Asian J Trop Med Public Health 31:521–523
Ogata M, Fukuda T, Teshima T (2015) Human herpesvirus-6 encephalitis after allogeneic hematopoietic cell transplantation: what we do and do not know. Bone Marrow Transplant 50:1030–1036
Isaacson E, Glaser CA, Forghani B, Amad Z, Wallace M, Armstrong RW, Exner MM, Schmid S (2005) Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis 40:890–893
Kawamura Y, Sugata K, Ihira M, Mihara T, Mutoh T, Asano Y, Yoshikawa T (2011) Different characteristics of human herpesvirus 6 encephalitis between primary infection and viral reactivation. J Clin Virol 51:12–19
Zerr DM, Gooley TA, Yeung L, Huang ML, Carpenter P, Wade JC, Corey L, Anasetti C (2001) Humanherpesvirus 6 reactivation and encephalitis in allogeneic bone marrow transplant recipients. Clin Infect Dis 33:763–771
Yoshikawa T, Ohashi M, Miyake F, Fujita A, Usui C, Sugata K, Suga S, Hashimoto S et al (2009) Exanthem subitum-associated encephalitis: nationwide survey in Japan. Pediatr Neurol 41:353–358
Donati D, Akhyani N, Fogdell-Hahn A, Cermelli C, Cassiani-Ingoni R, Vortmeyer A, Heiss JD, Cogen P et al (2003) Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61:1405–1411
Kawamura Y, Nakayama A, Kato T, Miura H, Ishihara N, Ihira M, Takahashi Y, Matsuda K et al (2015) Pathogenic role of human herpesvirus 6B infection in mesial temporal lobe epilepsy. J Infect Dis 212:1014–1021
Li JM, Lei D, Peng F, Zeng YJ, Li L, Xia ZL, Xia XQ, Zhou D (2011) Detection of human herpes virus 6B in patients with mesial temporal lobe epilepsy in West China and the possible association with elevated NF-κB expression. Epilepsy Res 94:1–9
Ortinski PI, Dong J, Mungenast A, Yue C, Takano H, Watson DJ, Haydon PG, Coulter DA (2010) Selective induction of astrocytic gliosis generates deficits in neuronal inhibition. Nat Neurosci 13:584–591
Robel S, Buckingham SC, Boni JL, Campbell SL, Danbolt NC, Riedemann T, Sutor B, Sontheimer H (2015) Reactive astrogliosis causes the development of spontaneous seizures. J Neurosci 35:3330–3345
Xu Z, Xue T, Zhang Z, Wang X, Xu P, Zhang J, Lei X, Li Y et al (2011) Role of signal transducer and activator of transcription-3 in up-regulation of GFAP after epilepsy. Neurochem Res 36:2208–2215
Caserta MT, Hall CB, Schnabel K, McIntyre K, Long C, Costanzo M, Dewhurst S, Insel R et al (1994) Neuroinvasion and persistence of human herpesvirus 6 in children. J Infect Dis 170:1586–1589
Opsahl ML, Kennedy PGE (2005) Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter. Brain 128:516–527
Mayne M, Cheadle C, Soldan SS, Cermelli C, Yamano Y, Akhyani N, Nagel JE, Taub DD et al (2001) Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J Virol 75:11641–11650
Reynaud JM, Horvat B (2013) Human herpesvirus 6 and neuroinflammation. ISRN Virology, Article ID 834890.
Alvarez-Lafuente R, Garcia-Montojo M, De Las Heras V, Dominguez-Mozo MI, Bartolome M, Arroyo R (2009) CD46 expression and HHV-6 infection in patients with multiple sclerosis. Acta Neurol Scand 120:246–250
Gautier-Smith PC (1965) Neurological complications of glandular fever (infectious mononucleosis). Brain 88:323–334
Russell J, Fisher M, Zivin JA, Sullivan J, Drachman DA (1985) Status epilepticus and Epstein-Barr virus encephalopathy. Diagnosis by modern serologic techniques. Arch Neurol 42:789–792
Bialek R, Haverkamp FA, Fichsel H (1990) Epstein-Barr virus infection as a cause of infantile spasms. Lancet 335:425
Eeg-Olofsson O, Bergström T, Andermann F, Andermann E, Olivier A, Rydenhag B (2004) Herpesviral DNA in brain tissue from patients with temporal lobe epilepsy. Acta Neurol Scand 109:169–174
Tselis AC (2014) Epstein-Barr virus infections of the nervous system. Handb Clin Neurol 123:285–305
Whitley RJ, Kimberlin DW (2005) Herpes simplex encephalitis: children and adolescents. Semin Pediatr Infect Dis 16:17–23
Ward KN, Ohrling A, Bryant NJ, Bowley JS, Ross EM, Verity CM (2012) Herpes simplex serious neurological disease in young children: incidence and long-term outcome. Arch Dis Child 97:162–165
Bradshaw MJ, Venkatesan A (2016) Herpes simplex Virus-1 encephalitis in adults: pathophysiology, diagnosis, and management. Neurotherapeutics 13:493–508
Solbrig MV, Adrian R, Chang DY, Perng GC (2006) Viral risk factor for seizures: pathobiology of dynorphin in herpes simplex viral (HSV-1) seizures in an animal model. Neurobiol Dis 23:612–620
Science M, MacGregor D, Richardson SE, Mahant S, Tran D, Bitnun A (2014) Central nervous system complications of varicella-zoster virus. J Pediatr 165:779–785
Granerod J, Ambrose HE, Davies NW, Clewley JP, Walsh AL, Morgan D, Cunningham R, Zuckerman M et al (2010) Causes of encephalitis and differences in their clinical presentations in England: a multicentre, population-based prospective study. Lancet Infect Dis 10:835–844
Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ (2006) Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin Infect Dis 43:1143–1151
Rafailidis PI, Mourtzoukou EG, Varbobitis IC, Falagas ME (2008) Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review. Virol J 5:47
Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL et al (1995) Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci U S A 92:7440–7444
Friedman JE, Lyons MJ, Cu G, Ablashl DV, Whitman JE, Edgar M, Koskiniemi M, Vaheri A et al (1999) The association of the human herpesvirus-6 and MS. Mult Scler 5:355–362
Yao K, Crawford JR, Komaroff AL, Ablashi DV, Jacobson S (2010) Review part 2: human herpesvirus-6 in central nervous system diseases. J Med Virol 82:1669–1678
Tomasik J, Smits SL, Leweke FM, Eljasz P, Pas S, Kahn RS, Osterhaus ADME, Bahn S, de Witte LD (2018). Virus discovery analyses on post-mortem brain tissue and cerebrospinal fluid of schizophrenia patients. Schizophr Res
Rotbart HA (1995) Enteroviral infections of the central nervous system. Clin Infect Dis 20:971–981
Shekhar K, Lye MS, Norlijah O, Ong F, Looi LM, Khuzaiah R, Marzuki I, Hussein I et al (2005) Deaths in children during an outbreak of hand, foot and mouth disease in Peninsular Malaysia-clinical and pathological characteristics. Med J Malaysia 60:297–304
Verboon-Maciolek MA, Groenendaal F, Hahn CD, Hellmann J, van Loon AM, Boivin G, de Vries LS (2008) Human parechovirus causes encephalitis with white matter injury in neonates. Ann Neurol 64:266–273
Stringer JL (2006) Models available for infection induced seizures. In: Pitkänen A, Schwartzkroin PA, Moshé SL (eds) Models of seizures and epilepsy. Elsevier Academic Press, Burlington, pp. 521–526
Solbrig MV, Adrian R, Baratta J, Lauterborn JC, Koob GF (2006) Kappa opioid control of seizures produced by a virus in an animal model. Brain 129:642–654
Getts DR, Matsumoto I, Müller M, Getts MT, Radford J, Shrestha B, Campbell IL, King NJ (2007) Role of IFN-gamma in an experimental murine model of West Nile virus-induced seizures. J Neurochem 103:1019–1030
Mori CM, Mori E, Favaro LL, Santos CR, Lara MC, Villalobos EM, Cunha EM, Brandao PE et al (2012) Equid herpesvirus type-1 exhibits neurotropism and neurovirulence in a mouse model. J Comp Pathol 146:202–210
Zukor K, Wang H, Siddharthan V, Julander JG, Morrey JD (2018) Zika virus-induced acute myelitis and motor deficits in adult interferon αβ/γ receptor knockout mice. J Neurovirol. https://doi.org/10.1007/s13365-017-0595-z
Bröer S, Käufer C, Haist V, Li L, Gerhauser I, Anjum M, Bankstahl M, Baumgärtner W et al (2016) Brain inflammation, neurodegeneration and seizure development following picornavirus infection markedly differ among virus and mouse strains and substrains. Exp Neurol 279:57–74
DePaula-Silva AB, Hanak TJ, Libbey JE, Fujinami RS (2017) Theiler’s murine encephalomyelitis virus infection of SJL/J and C57BL/6J mice: models for multiple sclerosis and epilepsy. J Neuroimmunol 308:30–42
Libbey JE, Kirkman NJ, Smith MCP, Tanaka T, Wilcox KS, White HS, Fujinami RS (2008) Seizures following picornavirus infection. Epilepsia 49:1066–1074
Libbey JE, Fujinami RS (2011) Neurotropic viral infections leading to epilepsy: focus on Theiler’s murine encephalomyelitis virus. Future Virol 6:1339–1350
Patel DC, Wallis G, Dahle EJ, McElroy PB, Thomson KE, Tesi RJ, Szymkowski DE, West PJ et al (2017) Hippocampal TNFα signaling contributes to seizure generation in an infection-induced mouse model of limbic epilepsy. eNeuro 4:e0105–17.2017
Stewart KA, Wilcox KS, Fujinami RS, White HS (2010) Development of postinfection epilepsy after Theiler’s virus infection of C57BL/6 mice. J Neuropathol Exp Neurol 69:1210–1219
Howe CL, LaFrance-Corey RG, Sundsbak RS, Sauer BM, LaFrance SJ, Buenz EJ, Schmalstieg WF (2012) Hippocampal protection in mice with an attenuated inflammatory monocyte response to acute CNS picornavirus infection. Sci Rep 2:545
Loewen JL, Barker-Haliski ML, Dahle EJ, White HS, Wilcox KS (2016) Neuronal injury, gliosis, and glial proliferation in two models of temporal lobe epilepsy. J Neuropathol Exp Neurol 75:366–378
Kirkman NJ, Libbey JE, Wilcox KS, White HS, Fujinami RS (2010) Innate but not adaptive immune responses contribute to behavioral seizures following viral infection. Epilepsia 51:454–464
Barker-Haliski ML, Dahle EJ, Heck TD, Pruess TH, Vanegas F, Wilcox KS, White HS (2015) Evaluating an etiologically-relevant platform for therapy development for temporal lobe epilepsy: effects of carbamazepine and valproic acid on acute seizures and chronic behavioral comorbidities in the Theiler’s murine encephalomyelitis virus mouse model. J Pharmacol Exp Ther 353:318–329
Libbey JE, Kirkman NJ, Wilcox KS, White HS, Fujinami RS (2010) Role for complement in the development of seizures following acute viral infection. J Virol 84:6452–6460
Buenz EJ, Sauer BM, Lafrance-Corey RG, Deb C, Denic A, German CL, Howe CL (2009) Apoptosis of hippocampal pyramidal neurons is virus independent in a mouse model of acute neurovirulent picornavirus infection. Am J Pathol 175:668–684
Stewart KA, Wilcox KS, Fujinami RS, White HS (2010) Theiler’s virus infection chronically alters seizure susceptibility. Epilepsia 51:1418–1428
Umpierre AD, Remigio GJ, Dahle EJ, Bradford K, Alex AB, Smith MD, West PJ, White HS et al (2014) Impaired cognitive ability and anxiety-like behavior following acute seizures in the Theiler’s virus model of temporal lobe epilepsy. Neurobiol Dis 64:98–106
Barker-Haliski ML, Heck TD, Dahle EJ, Venagas F, Pruess TH, Wilcox KS, White HS (2016) Acute treatment with minocycline, but not valproic acid, improves long-term behavioral out-comes in the Theiler’s virus model of temporal lobe epilepsy. Epilepsia 57:1958–1967
Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS (2011) Lack of correlation of central nervous system inflammation and neuropathology with the development of seizures following acute virus infection. J Virol 85:8149–8157
Carrithers MD (2014) Innate immune viral recognition: relevance to CNS infections. Handb Clin Neurol 123:215–223
DePaula-Silva AB, Sonderegger FL, Libbey JE, Doty DJ, Fujinami RS (2018) The immune response to picornavirus infection and the effect of immune manipulation on acute seizures. J Neurovirol
Howe CL, LaFrance-Corey RG, Sundsbak RS, LaFrance SJ (2012) Inflammatory monocytes damage the hippocampus during acute picornavirus infection of the brain. J Neuroinflammation 9:50
Cusick MF, Libbey JE, Patel DC, Doty DJ, Fujinami RS (2013) Infiltrating macrophages are key to the development of seizures following virus infection. J Virol 87:1849–1860
Waltl I, Kaufer C, Broer S, Chhatbar C, Ghita L, Gerhauser I, Anjum M, Kalinke U et al (2018) Macrophage depletion by liposome-encapsulated clodronate suppresses seizures but not hippocampal damage after acute viral encephalitis. Neurobiol Dis 110:192–205
Howe CL, LaFrance-Corey RG, Mirchia K, Sauer BM, McGovern RM, Reid JM, Buenz EJ (2016) Neuroprotection mediated by inhibition of calpain during acute viral encephalitis. Sci Rep 6:28699
Howe CL, LaFrance-Corey RG, Goddery EN, Johnson RK, Mirchia K (2017) Neuronal CCL2 expression drives inflammatory monocyte infiltration into the brain during acute virus infection. J Neuroinflammation 14:238
Libbey JE, Cusick MF, Doty DJ, Fujinami RS (2017) Complement components are expressed by infiltrating macrophages/activated microglia early following viral infection. Viral Immunol 30:304–314
Libbey JE, Kennett NJ, Wilcox KS, White HS, Fujinami RS (2011) Interleukin-6, produced by resident cells of the central nervous system and infiltrating cells, contributes to the development of seizures following viral infection. J Virol 85:6913–6922
Libbey JE, Fujinami RS (2014) Adaptive immune response to viral infections in the central nervous system. Handb Clin Neurol 123:225–247
Cusick MF, Libbey JE, Doty DJ, DePaula-Silva AB, Fujinami RS (2017) The role of peripheral Interleukin-6 in the development of seizures following virus encephalitis. J Neurovirol 23:696–703
Zurbriggen A, Thomas C, Yamada M, Roos R, Fujinami RS (1991) Direct evidence of a role for amino acid 101 of VP-1 in central nervous system disease in Theiler's murine encephalomyelitis virus infection. J Virol 65:1929–1937
Cusick MF, Libbey JE, Doty DJ, Fujinami RS (2014) DA virus mutant H101 has altered CNS pathogenesis and causes immunosuppression. J Neuroimmunol 277:118–126
Alapirtti T, Lehtimaki K, Nieminen R, Makinen R, Raitanen J, Moilanen E, Makinen J, Peltola J (2018) The production of IL-6 in acute epileptic seizure: a video-EEG study. J Neuroimmunol 316:50–55
Hu S, Sheng WS, Ehrlich LC, Peterson PK, Chao CC (2000) Cytokine effects on glutamate uptake by human astrocytes. Neuroimmunomodulation 7:153–159
Vereyken EJ, Bajova H, Chow S, de Graan PN, Gruol DL (2007) Chronic interleukin-6 alters the level of synaptic proteins in hippocampus in culture and in vivo. Eur J Neurosci 253:605–616
Garcia-Oscos F, Salgado H, Hall S, Thomas F, Farmer GE, Bermeo J, Galindo LC, Ramirez RD et al (2012) The stress-induced cytokine interleukin-6 decreases the inhibition/excitation ratio in the rat temporal cortex via trans-signaling. Biol Psychiatry 71:574–582
Libbey JE, Hanak TJ, Doty DJ, Wilcox KS, Fujinami RS (2016) NBQX, a highly selective competitive antagonist of AMPA and KA ionotropic glutamate receptors, increases seizures and mortality following picornavirus infection. Exp Neurol 280:89–96
Smeal RM, Stewart KA, Iacob E, Fujinami RS, White HS, Wilcox KS (2012) The activity within the CA3 excitatory network during Theiler's virus encephalitis is distinct from that observed during chronic epilepsy. J Neuro-Oncol 18:30–44
Smeal RM, Fujinami R, White HS, Wilcox KS (2015) Decrease in CA3 inhibitory network activity during Theiler's virus encephalitis. Neurosci Lett 609:210–215
Funding
Dr. Bartolini reports receiving grant support from the American Epilepsy Society and Epilepsy Foundation of America. Dr. Ravizza reports receiving grant support from the European Union’s Seventh Framework Programme (FP7/2007-2013) under grant agreement n°602102 (EPITARGET), and Fondazione Italo Monzino. Dr. Gaillard reports receiving grant support from NIH, CDC, NSF, PCORI, American Epilepsy Society, Epilepsy Foundation, CURE, and the Pediatric Epilepsy Research Foundation. Dr. Fujinami reports receiving grant support from NIH (R01NS065714).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Bartolini, L., Libbey, J.E., Ravizza, T. et al. Viral Triggers and Inflammatory Mechanisms in Pediatric Epilepsy. Mol Neurobiol 56, 1897–1907 (2019). https://doi.org/10.1007/s12035-018-1215-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-018-1215-5